1 / 16

MIDTNET SECTOR REPORT

MIDTNET SECTOR REPORT. LIFE SCIENCE SUMMARY. prepared by INNOVATION CENTER DENMARK. MIDTNET SECTOR REPORT. LIFE SCIENCE FOCUS AREAS IN SHANGHAI. Elderly Care New Drug Discovery IVF-ET TCM Development. MIDTNET SECTOR REPORT. ELDERLY CARE: Challenges & Obstacles.

amish
Télécharger la présentation

MIDTNET SECTOR REPORT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MIDTNET SECTOR REPORT LIFE SCIENCE SUMMARY prepared by INNOVATION CENTER DENMARK

  2. MIDTNET SECTOR REPORT LIFE SCIENCE FOCUS AREAS IN SHANGHAI • Elderly Care • New Drug Discovery • IVF-ET • TCM Development

  3. MIDTNET SECTOR REPORT ELDERLY CARE: Challenges & Obstacles • Lack of Care Products for the Elderly • Inadequate Human and Material Resources • Developing Home Care Services • The Chinese Tradition and Expectations from the Elderly • Pursuit of Higher Life Quality • Preference to Stay in a Care Home • Affordability by the Elderly • Low Pension of Retired People • Families of ‘421’ Structure

  4. MIDTNET SECTOR REPORT ELDERLY CARE: Conclusions & Suggestions • A huge demand for proper affordable elder care facilities • A great need for comprehensive solutions in local hospitals • toilets, kitchen wares, beds, movement auxiliaries, fitness equipment and all kinds of software • well-trained elder care nurses

  5. MIDTNET SECTOR REPORT ELDERLY CARE: Potential Partners/ Competitors • Personal Care Products • Massagers, thermotherapy machine, lavipeditum instruments, etc. • (Massagers for elderly are very popular products on the Chinese market.) • Electronic Hearing Aids • (International brands dominate this part of the market in China.) • Personal Monitoring Instruments  • The Electronic Sphygmomanometer • (Omron is now the largest manufacturer nationwide.) • The Electronic Blood Glucose Monitor • (Foreign brands such as Johnson and Johnson (U.S) and Roche (Germany) occupy the majority of the market.)

  6. MIDTNET SECTOR REPORT ELDERLY CARE: Potential Partners/ Competitors • The Rehabilitation Department of Zhongshan Hospital, Fudan University • The Rehabilitation Department of Huashan Hospital • The Rehabilitation Department of Ruijin Hospital • The Rehabilitation and Sports Medicine Department of Shanghai Medical College, Fudan University

  7. MIDTNET SECTOR REPORT NEW DRUG DISCOVERY : Two Major Groups of Enterprises • Pharmaceutical manufacturers • Large CROs

  8. MIDTNET SECTOR REPORT Pharmaceutical Manufacturers: Potential Partners/ Competitors • Fosun Pharma • The most active and innovative pharmaceutical enterprise in China, which focuses on Diabetics, Hepatopathy, Cardiovascular, Oncology, and Infection • Shanghai Pharmaceuticals Holding Co., Ltd • The largest medical group, whose department of raw materials is responsible for the manufacturing of bulk drugs for nervus centralis, respiratory system, antibiotic, diabetes, anti-anaphylaxis, anti-tumor, angiocarpy, and mental diseases • Hutchison Medipharma • Focusing on oncology, autoimmune disease and diabetes • Simcere Pharma • A leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug • HengRui Medicine • Primarily in anti-cancer, antineoplastics, angiomyocardiac, analgesic and antibiotics, etc

  9. MIDTNET SECTOR REPORT Large CROs: Potential Partners/ Competitors • Wuxi Pharma • A R&D outsourcing company that focuses on pharmaceuticals, biotechnology and medical devices • ChemExplorer / ChemPartner • One of the leading integrated chemistry service organizations in China/ An exclusive outsourcing company of a major U.S. Pharmaceutical company

  10. MIDTNET SECTOR REPORT IVF-ET: Challenges & Obstacles • Delaying Marriage and Childbearing Age • The average marriage age is 32.05 for male and 29.38 for female in 2009. • In 2008, women’s age at first childbearing was 27.9 in Shanghai. • Rising Infertility Cases • The infertility rate among these couples has exceeded 10%, and is continuously increasing. • High Cost of IVF • The total cost shall be between 20,000~30,000 CNY. • Unstable Success Rate • Limited Resources of IVF medicine

  11. MIDTNET SECTOR REPORT IVF-ET : Conclusions & Suggestions • A huge demand for advanced technologies and facilities

  12. MIDTNET SECTOR REPORT IVF-ET: Potential Partners/ Competitors • International Peace Maternity and Child Hygiene Hospital. • The success rate of IVF-ET in 2002 was 43.96%. • Ruijin Hospital, Shanghai Jiaotong University School of Medicine • Renji Hospital, Shanghai Jiaotong University School of Medicine • ShangHai JiAi Genetics & IVF Institute • Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine • Shanghai First Maternity and Child Hygiene Hospital • Shanghai Red House Hospital of Obstetrics and Gynecology

  13. MIDTNET SECTOR REPORT TCM DEVELOPMENT: Challenges & Obstacles • Hard to ration out all ingredients • Hard to analyze effective components • Hard to find out essential active substances

  14. MIDTNET SECTOR REPORT TCM DEVELOPMENT: Conclusions & Suggestions • Need for help to improve the extraction methods and efficiency and • Need for analysis and identification of effective components as well as doing the experimental analysis afterwards • Further development of the ingredients that cannot be developed into medicine

  15. MIDTNET SECTOR REPORT TCM DEVELOPMENT : Potential Partners/ Competitors • Famous TCM Companies in Shanghai • Shanghai Leiyunshang Medicine Co., Ltd. • Afflicted to Shanghai Pharmaceuticals Holdings Co., Ltd., Leiyunshang has a GMP base for mass manufacturing TCM which is able to produce over 20 dosage forms and 500 types. • Tonghanchun Tang • Caitongde Tang • Huqingyu Tang

  16. MIDTNET SECTOR REPORT TCM DEVELOPMENT : Potential Partners/ Competitors • Famous TCM Institutes in Shanghai • Shanghai University of T.C.M • Shanghai Institute of Chinese Meteria Medica • School of Pharmacy, Fudan University • Shanghai Shuguang Hospital, Shanghai University of T.C.M • Shanghai Longhua Hospital, Shanghai University of T.C.M

More Related